Zomedica Strengthens Market Position with New Patents Issued for its TRUFORMA(R) Diagnostic Platform

Stock Information for Moving iMage Technologies Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Moving iMage Technologies Inc.

Zomedica Releases Over-the-Air Software Update Capabilities for Its TRUFORMA(R) Platform
Zomedica Announces First Quarter 2024 Financial Results: Revenue up 14% to $6.3 Million; 66% Gross Margin, and $91 Million in Liquidity
Zomedica to Present at the EF Hutton Annual Global Conference on May 15, 2024
Zomedica Expands International Reach with CE Certification for VetGuardian(R) System
Zomedica to Report First Quarter 2024 Financial Results and Provide Business Update on May 9th at 4:30 p.m. ET
Zomedica to Present at the Noble Capital Markets Virtual Healthcare Conference on April 17, 2024
Zomedica Reports Record Revenue of $7.3 Million for the Fourth Quarter and $25.2 Million for the Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin and $100.5 Million in Liquidity
Zomedica to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Monday, April 1, 2024, at 4:30 p.m. ET

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.